Article(id=1304406830399124244, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.02.005, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1754928000000, receivedDateStr=2025-08-12, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788924423074, onlineDateStr=2026-09-09, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788924423074, onlineIssueDateStr=2026-09-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788924423074, creator=13701087609, updateTime=1788924423074, updator=13701087609, issue=Issue{id=1304406828071281069, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='2', pageStart='393', pageEnd='788', issueExtLink='null', onlineDate='null', pubDate='1769529600000', pubDateStr='2026-01-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1788924422518, creator='13701087609', updateTime=1788924652596, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304407793138688830, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304407793138688831, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=425, endPage=437, ext={EN=ArticleExt(id=1304406830772417302, articleId=1304406830399124244, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Dose-effect change rule of characteristic chemical components and in Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos herb pair with different compatibility ratios and antithrombotic activity, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To analyze the correlation between the content changes of characteristic components and its antithrombotic effect in different proportions of the Danshen (Salviae Miltiorrhizae Radix et Rhizoma, SMRR)-Honghua (Carthami Flos, CF) herb pair, and optimize the compatibility ratio of SMRR and CF for promoting blood circulation and removing blood stasis. Methods Fingerprint profiles and quantitative determination methods for characteristic components were established for SMRR-CF herb pair at different ratios (1:1, 1:2, 1:3, 1:4, 1:5, 2:1, 3:1, 4:1, 5:1). The HPLC combined with a comprehensive scoring method was used to determine the optimal extraction process of the SMRR-CF herb pair. The anti-thrombotic activity of the SMRR-CF extracts at different ratios was measured using zebrafish as a model organism. The principal component analysis (PCA) method was used to integrate the content of characteristic components and the intensity of antithrombotic activity, and the optimal ratio of SMRR and CF was comprehensively evaluated from two aspects of composition and efficacy. Results The fingerprint profiles of the SMRR-CF herb pair in nine different ratios collectively identified 17 common peaks, among which nine characteristic components were characterized. These include hydroxysafflor yellow A (peak 2), luteoloside (peak 3), kaempferol-3-O-rutinoside (peak 4), quercitrin (peak 5), salvianolic acid B (peak 8), dihydrotanshinone I (peak 12), cryptotanshinone (peak 14), tanshinone I (peak 15), and tanshinone IIA (peak 17). The optimal extraction process was determined to be maceration with 10 times the amount of 70% ethanol for 1 h by reflux. The content determination showed that the characteristic components changed significantly after the compatibility of SMRR and CF compared with the single herb. When the SMRR-CF ratio was 1:5, decoction yielded the highest concentrations of salvianolic acids and tanshinones derived from SMRR. Conversely, ratios of 3:1, 4:1 and 5:1 produced the greatest amounts of hydroxysafflor yellow A, luteoloside and kaempferol-3-O-rutinoside from CF, indicating that co-decoction facilitates the extraction of bioactive constituents from both herbs. Pharmacodynamic evaluation revealed that the 3:1 ratio exhibited the strongest antithrombotic activity, achieving a thrombosis inhibition rate of 43.7%. Principal-component analysis of the “composition-effect” dataset ranked the comprehensive indices (F-values) as 3:1 > 4:1 > 5:1 > 2:1 > 1:1 > 1:5 > 1:4 > 1:2 > 1:3, confirming that the 3:1 ratio represents the optimal compatibility of the SMRR-CF pair. Conclusion In this study, chemical profiling and in vivo pharmacodynamic evaluation were integrated to elucidate the quantitative relationship between the dynamic changes of characteristic constituents and the antithrombotic efficacy of the SMRR-CF herb pair across different compatibility ratios. An optimal ratio was identified through a “composition-effect”-based comprehensive assessment. These findings not only establish a foundation for subsequent dose-effect investigations of this classic combination, but also offer a rational reference for determining prescription design in latent prescriptions., authors=LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng, authorsList=LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304406830680142613, articleId=1304406830399124244, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=丹参-红花药对不同配比特征化学成分与抗血栓活性的量-效变化规律研究, columnId=1304140189132149234, journalTitle=中草药, columnName=药剂与工艺, runingTitle=null, highlight=null, articleAbstract=目的 综合分析丹参SalviaeMiltiorrhizae Radix et Rhizoma-红花Carthami Flos药对不同配比的特征化学成分含量与其抗血栓作用变化规律,优化丹参-红花药对活血化瘀配伍比例。方法 建立丹参-红花药对不同配比(1∶1、1∶2、1∶3、1∶4、1∶5、2∶1、3∶1、4∶1、5∶1)的指纹图谱及特征成分定量测定方法;采用HPLC法结合综合评分法对丹参-红花药对的提取工艺进行考察,确定最佳提取工艺;以斑马鱼模式生物测定不同配比丹参-红花提取物的抗血栓活性;采用主成分分析(principal component analysis,PCA)法整合特征成分含量与抗血栓活性强度,从成分和药效2个层面综合评价丹参-红花药对的最佳配比。结果 9种配比的丹参-红花药对指纹图谱共确定了17个共有峰,其中指认了9种特征成分,分别为羟基红花黄色素A(2号峰)、木犀草苷(3号峰)、山柰酚-3-O-芸香糖苷(4号峰)、槲皮苷(5号峰)、丹酚酸B(8号峰)、二氢丹参酮I(12号峰)、隐丹参酮(14号峰)、丹参酮I(15号峰)、丹参酮IIA(17号峰);最佳提取工艺为10倍量70%乙醇,回流提取1 h。含量测定结果显示,丹参-红花配伍后相比单味药材,特征成分含量发生明显变化,配伍比例为1∶5时丹参中特有的丹酚酸和丹参酮类成分含量较高,配伍比例为3∶1、4∶1、5∶1时红花中指标性成分羟基红花黄色素A、木犀草苷、山柰酚-3-O-芸香糖苷的含量相对较高,提示丹参-红花共煎会促进有效成分的溶出;抗血栓效应显示,丹参-红花配比为3∶1时具有最好的抗血栓活性,预防血栓率达43.7%。PCA结果显示,丹参-红花配伍“成分-效应”综合评价指标(F值)排序为3∶1>4∶1>5∶1>2∶1>1∶1>1∶5>1∶4>1∶2>1∶3,表明3∶1为丹参-红花的最佳配伍比例。结论 通过化学成分分析和体内活性评价,揭示了不同配比丹参-红花药对的特征成分含量变化与抗血栓作用的相关性,通过“成分-效应”综合评价解释最佳配伍比例,为进一步开展该药对的量-效关联性分析奠定了基础,也为临床遣方时确定适宜用量提供参考。, authors=蓝婷婷1,2, 赵青荣1,2, 余代鑫1,2, 吴啟南1,2,3, 瞿城1,2,3, authorsList=蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城, authorCompany=1 南京中医药大学药学院, 江苏 南京 210023;
2 江苏省中药资源产业化过程协同创新中心, 江苏 南京 210023;
3 中药资源产业化与方剂创新药物国家地方联合工程研究中心, 江苏 南京 210023, correspAuthors=吴啟南, authorNote=蓝婷婷: 蓝婷婷,女,硕士研究生,研究方向为中药资源与鉴定。E-mail: 13557572631@163.com 赵青荣: 瞿城,男,讲师,主要从事中药品质评价及功效物质研究。E-mail: qucheng@njucm.edu.cn, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=ppKF9LiKowRI+9o626vuZA==, pdfFileSize=2209067, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=国家自然科学基金资助项目 (82204597); 南京中医药大学自然科学基金项目 (XPT82204597); 江苏省研究生科研与实践创新计划项目 (KYCX25_2373))}, authors=[Author(id=1307452065769349652, tenantId=1146029695717560320, journalId=null, articleId=1304406830399124244, orderNo=null, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=null, authorType=null, ext={EN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1304406830399124244, authorId=1307452065769349652, language=EN, stringName=LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1304406830399124244, authorId=1307452065769349652, language=CN, stringName=蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=null)], keywords=[Keyword(id=1304406831028269847, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=1, keyword=丹参-红花药对), Keyword(id=1304406831091184408, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=2, keyword=指纹图谱), Keyword(id=1304406831166681881, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=3, keyword=抗血栓效应), Keyword(id=1304406831237985050, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=4, keyword=主成分分析), Keyword(id=1304406831309288219, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=5, keyword=配伍优化), Keyword(id=1304406831384785692, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=6, keyword=量-效关联), Keyword(id=1304406831468671773, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=7, keyword=HPLC), Keyword(id=1304406831544169246, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=8, keyword=羟基红花黄色素A), Keyword(id=1304406831628055327, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=9, keyword=木犀草苷), Keyword(id=1304406831716135712, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=10, keyword=山柰酚-3-O-芸香糖苷), Keyword(id=1304406831829381921, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=11, keyword=槲皮苷), Keyword(id=1304406831900685090, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=12, keyword=丹酚酸B), Keyword(id=1304406831967793955, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=13, keyword=二氢丹参酮I), Keyword(id=1304406832034902820, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=14, keyword=隐丹参酮), Keyword(id=1304406832110400293, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=15, keyword=丹参酮I), Keyword(id=1304406832248812326, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=CN, orderNo=16, keyword=丹参酮IIA), Keyword(id=1304406832332698407, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=1, keyword=Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos herb pair), Keyword(id=1304406832420778792, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=2, keyword=fingerprint), Keyword(id=1304406832487887657, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=3, keyword=antithrombotic effect), Keyword(id=1304406832554996522, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=4, keyword=principal component analysis), Keyword(id=1304406832622105387, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=5, keyword=compatibility optimization), Keyword(id=1304406832693408556, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=6, keyword=dose-effect correlation), Keyword(id=1304406832773100333, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=7, keyword=HPLC), Keyword(id=1304406832844403502, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=8, keyword=hydroxysafflor yellow A), Keyword(id=1304406832911512367, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=9, keyword=luteoloside), Keyword(id=1304406832991204144, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=10, keyword=kaempferol-3-O-rutinoside), Keyword(id=1304406833054118705, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=11, keyword=quercitrin), Keyword(id=1304406834736034610, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=12, keyword=salvianolic acid B), Keyword(id=1304406834836697907, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=13, keyword=dihydrotanshinone I), Keyword(id=1304406834941555508, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=14, keyword=cryptotanshinone), Keyword(id=1304406835012858677, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=15, keyword=tanshinone I), Keyword(id=1304406835084161846, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406830399124244, language=EN, orderNo=16, keyword=tanshinone IIA)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.02.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.02.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501/j.issn.0253-2670.2026.02.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501/j.issn.0253-2670.2026.02.005, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1788924423074, fullTextJson=null, articleText=null, reference=邓树泳, 李静, 罗来成. 中药药对的现代研究进展[J]. 时珍国医国药, 2012, 23(4):1003-1005.
候宁, 吴东雪, 刘敏, 等. 基于药性组合的丹参和红花的性效关系研究[J]. 中国中药杂志, 2019, 44(2):224-228.
刘玥, 高铸烨, 付长庚, 等. 活血化瘀药物防治冠心病:循证与展望[J]. 中国循证医学杂志, 2018, 18(11):1145-1150.
郝晨伟, 李正翔, 张铭慧, 等. 丹参及其配伍制剂治疗冠心病的研究进展[J]. 中草药, 2021, 52(13):4096-4106.
卜雕雕, 苏卓, 柏希慧, 等. 基于网络药理学的丹参-红花治疗心肌梗死的作用及其机制研究[J]. 中草药, 2020, 51(10):2807-2818.
薛志鹏, 杜少兵, 周慧慧, 等. 基于网络药理学和实验验证的丹参-红花药对治疗心肌缺血的作用机制探讨[J]. 药物评价研究, 2023, 46(4):759-771.
蔡光先. 心宁片治疗冠心病心绞痛临床观察[J]. 世界科学技术-中医药现代化, 2010, 12(4):571-574.
Feng X J, Li Y, Wang Y N, et al. Danhong injection in cardiovascular and cerebrovascular diseases:Pharmacological actions, molecular mechanisms, and therapeutic potential[J]. Pharmacol Res, 2019, 139:62-75.
赖旻. 白癜风胶囊联合芪胶升白胶囊治疗白癜风患者的临床效果研究[J]. 中国实用医药, 2024, 19(9):128-131.
Zhao Q R, Yu D X, Lan T T, et al. Danshen-Honghua herb pair:A review on chemical constituents, pharmacology, clinical application, quality control, and t-copula function analysis[J]. J Ethnopharmacol, 2026, 354:120476.
Lan T T, Yu D X, Zhao Q R, et al. Ethnomedicine, phytochemistry, pharmacology, pharmacokinetics, and clinical application of Salvia miltiorrhiza Bunge (Lamiaceae):A comprehensive review[J]. J Ethnopharmacol, 2025, 350:120032.
Pan J J, Wang J H, Lei Z W, et al. Therapeutic potential of Chinese herbal medicine and underlying mechanism for the treatment of myocardial infarction[J]. Phytother Res, 2025, 39(1):189-232.
邢耀莹, 王姿杨, 王露, 等. 牛蒡子-甘草药对指纹图谱的建立及其抗炎活性谱效关系研究[J]. 中草药, 2024, 55(4):1237-1247.
罗浩睿, 庄雪菲, 李曦东, 等. 黄连-苦参不同配比中特征性成分的量-质变化相关性研究[J]. 中草药, 2024, 55(12):3977-3986.
耿飞飞, 曲彤, 李宁, 等. 青风藤-白芍药对不同配伍比例化学成分与抗炎活性变化规律研究[J]. 中草药, 2025, 56(1):98-107.
李响, 俱蓉, 李硕. 红花化学成分药理作用研究进展及质量标志物预测分析[J]. 中国现代中药, 2021, 23(5):928-939.
Zhang X L, Shen D Y, Feng Y T, et al. Pharmacological actions, molecular mechanisms, pharmacokinetic progressions, and clinical applications of hydroxysafflor yellow A in antidiabetic research[J]. J Immunol Res, 2021, 2021:4560012.
Wang W X, Liu M, Fu X L, et al. Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways[J]. Phytomedicine, 2024, 132:155814.
Feng X T, Du M, Li S J, et al. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE−/− mice[J]. Phytomedicine, 2023, 112:154684.
Hua F, Li J Y, Zhang M, et al. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction[J]. J Food Biochem, 2022, 46(10):e14305.
Xia K R, Zhang X Y, Zhang H Q, et al. Network pharmacology analysis and experimental verification of the antithrombotic active compounds of Trichosanthis Pericarpium (Gualoupi) in treating coronary heart disease[J]. J Ethnopharmacol, 2024, 329:118158.
Oh T W, Do H J, Jeon J H, et al. Quercitrin inhibits platelet activation in arterial thrombosis[J]. Phytomedicine, 2021, 80:153363.
Li H Y, Gao C D, Liu C, et al. A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen[J]. Biomed Pharmacother, 2021, 137:111332.
MEIm X D, Cao Y F, Che Y Y, et al. Danshen:A phytochemical and pharmacological overview[J]. Chin J Nat Med, 2019, 17(1):59-80.
廖江龙, 范子祥, 孟秋月, 等. 丹参活性成分抗肿瘤分子机制研究进展[J]. 中草药, 2024, 55(18):6402-6415.
屈媛, 王婷, 付慧婕, 等. 丹参有效成分及药理作用研究进展[J]. 辽宁中医药大学学报, 2024, 26(9):172-176.
Yang Y F, Feng K, Yuan L Y, et al. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis- induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms[J]. Acta Pharm Sin B, 2023, 13(3):1036-1052.
Li Z M, Xu S W, Liu P Q. Salvia miltiorrhiza Bunge (Danshen):A golden herbal medicine in cardiovascular therapeutics[J]. Acta Pharmacol Sin, 2018, 39(5):802-824.
Xue Y J, Zhang L Y, Zhang L S, et al. Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk[J]. Phytomedicine, 2022, 104:154271.
魏吉昌, 林晓钰, 张景怡, 等. 基于相态变化探讨煎煮方式对黄芩-黄连超分子物质基础及配伍"和合"机制的影响[J]. 中草药, 2024, 55(24):8366-8378.)
收藏切换
丹参-红花药对不同配比特征化学成分与抗血栓活性的量-效变化规律研究
收藏切换
PDF下载
蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城
中草药 | 药剂与工艺 2026,57(2): 425-437
收起
收藏切换
中草药 |药剂与工艺 2026 , 57 (2) : 425 -437
丹参-红花药对不同配比特征化学成分与抗血栓活性的量-效变化规律研究
全屏
[Author(id=1307452065769349652, tenantId=1146029695717560320, journalId=null, articleId=1304406830399124244, orderNo=null, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=null, authorType=null, ext={EN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1304406830399124244, authorId=1307452065769349652, language=EN, stringName=LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=null, tenantId=null, journalId=1302319053441957962, articleId=1304406830399124244, authorId=1307452065769349652, language=CN, stringName=蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=null)]
蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城
作者信息
通讯作者:
吴啟南
作者简介:
蓝婷婷: 蓝婷婷,女,硕士研究生,研究方向为中药资源与鉴定。E-mail: 13557572631@163.com 赵青荣: 瞿城,男,讲师,主要从事中药品质评价及功效物质研究。E-mail: qucheng@njucm.edu.cn
Dose-effect change rule of characteristic chemical components and in Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos herb pair with different compatibility ratios and antithrombotic activity
LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.02.005
文章导航
收藏切换
目的 综合分析丹参SalviaeMiltiorrhizae Radix et Rhizoma-红花Carthami Flos药对不同配比的特征化学成分含量与其抗血栓作用变化规律,优化丹参-红花药对活血化瘀配伍比例。方法 建立丹参-红花药对不同配比(1∶1、1∶2、1∶3、1∶4、1∶5、2∶1、3∶1、4∶1、5∶1)的指纹图谱及特征成分定量测定方法;采用HPLC法结合综合评分法对丹参-红花药对的提取工艺进行考察,确定最佳提取工艺;以斑马鱼模式生物测定不同配比丹参-红花提取物的抗血栓活性;采用主成分分析(principal component analysis,PCA)法整合特征成分含量与抗血栓活性强度,从成分和药效2个层面综合评价丹参-红花药对的最佳配比。结果 9种配比的丹参-红花药对指纹图谱共确定了17个共有峰,其中指认了9种特征成分,分别为羟基红花黄色素A(2号峰)、木犀草苷(3号峰)、山柰酚-3-O-芸香糖苷(4号峰)、槲皮苷(5号峰)、丹酚酸B(8号峰)、二氢丹参酮I(12号峰)、隐丹参酮(14号峰)、丹参酮I(15号峰)、丹参酮IIA(17号峰);最佳提取工艺为10倍量70%乙醇,回流提取1 h。含量测定结果显示,丹参-红花配伍后相比单味药材,特征成分含量发生明显变化,配伍比例为1∶5时丹参中特有的丹酚酸和丹参酮类成分含量较高,配伍比例为3∶1、4∶1、5∶1时红花中指标性成分羟基红花黄色素A、木犀草苷、山柰酚-3-O-芸香糖苷的含量相对较高,提示丹参-红花共煎会促进有效成分的溶出;抗血栓效应显示,丹参-红花配比为3∶1时具有最好的抗血栓活性,预防血栓率达43.7%。PCA结果显示,丹参-红花配伍“成分-效应”综合评价指标(F值)排序为3∶1>4∶1>5∶1>2∶1>1∶1>1∶5>1∶4>1∶2>1∶3,表明3∶1为丹参-红花的最佳配伍比例。结论 通过化学成分分析和体内活性评价,揭示了不同配比丹参-红花药对的特征成分含量变化与抗血栓作用的相关性,通过“成分-效应”综合评价解释最佳配伍比例,为进一步开展该药对的量-效关联性分析奠定了基础,也为临床遣方时确定适宜用量提供参考。
丹参-红花药对  /  指纹图谱  /  抗血栓效应  /  主成分分析  /  配伍优化  /  量-效关联  /  HPLC  /  羟基红花黄色素A  /  木犀草苷  /  山柰酚-3-O-芸香糖苷  /  槲皮苷  /  丹酚酸B  /  二氢丹参酮I  /  隐丹参酮  /  丹参酮I  /  丹参酮IIA
Objective To analyze the correlation between the content changes of characteristic components and its antithrombotic effect in different proportions of the Danshen (Salviae Miltiorrhizae Radix et Rhizoma, SMRR)-Honghua (Carthami Flos, CF) herb pair, and optimize the compatibility ratio of SMRR and CF for promoting blood circulation and removing blood stasis. Methods Fingerprint profiles and quantitative determination methods for characteristic components were established for SMRR-CF herb pair at different ratios (1:1, 1:2, 1:3, 1:4, 1:5, 2:1, 3:1, 4:1, 5:1). The HPLC combined with a comprehensive scoring method was used to determine the optimal extraction process of the SMRR-CF herb pair. The anti-thrombotic activity of the SMRR-CF extracts at different ratios was measured using zebrafish as a model organism. The principal component analysis (PCA) method was used to integrate the content of characteristic components and the intensity of antithrombotic activity, and the optimal ratio of SMRR and CF was comprehensively evaluated from two aspects of composition and efficacy. Results The fingerprint profiles of the SMRR-CF herb pair in nine different ratios collectively identified 17 common peaks, among which nine characteristic components were characterized. These include hydroxysafflor yellow A (peak 2), luteoloside (peak 3), kaempferol-3-O-rutinoside (peak 4), quercitrin (peak 5), salvianolic acid B (peak 8), dihydrotanshinone I (peak 12), cryptotanshinone (peak 14), tanshinone I (peak 15), and tanshinone IIA (peak 17). The optimal extraction process was determined to be maceration with 10 times the amount of 70% ethanol for 1 h by reflux. The content determination showed that the characteristic components changed significantly after the compatibility of SMRR and CF compared with the single herb. When the SMRR-CF ratio was 1:5, decoction yielded the highest concentrations of salvianolic acids and tanshinones derived from SMRR. Conversely, ratios of 3:1, 4:1 and 5:1 produced the greatest amounts of hydroxysafflor yellow A, luteoloside and kaempferol-3-O-rutinoside from CF, indicating that co-decoction facilitates the extraction of bioactive constituents from both herbs. Pharmacodynamic evaluation revealed that the 3:1 ratio exhibited the strongest antithrombotic activity, achieving a thrombosis inhibition rate of 43.7%. Principal-component analysis of the “composition-effect” dataset ranked the comprehensive indices (F-values) as 3:1 > 4:1 > 5:1 > 2:1 > 1:1 > 1:5 > 1:4 > 1:2 > 1:3, confirming that the 3:1 ratio represents the optimal compatibility of the SMRR-CF pair. Conclusion In this study, chemical profiling and in vivo pharmacodynamic evaluation were integrated to elucidate the quantitative relationship between the dynamic changes of characteristic constituents and the antithrombotic efficacy of the SMRR-CF herb pair across different compatibility ratios. An optimal ratio was identified through a “composition-effect”-based comprehensive assessment. These findings not only establish a foundation for subsequent dose-effect investigations of this classic combination, but also offer a rational reference for determining prescription design in latent prescriptions.
Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos herb pair  /  fingerprint  /  antithrombotic effect  /  principal component analysis  /  compatibility optimization  /  dose-effect correlation  /  HPLC  /  hydroxysafflor yellow A  /  luteoloside  /  kaempferol-3-O-rutinoside  /  quercitrin  /  salvianolic acid B  /  dihydrotanshinone I  /  cryptotanshinone  /  tanshinone I  /  tanshinone IIA
蓝婷婷, 赵青荣, 余代鑫, 吴啟南, 瞿城. 丹参-红花药对不同配比特征化学成分与抗血栓活性的量-效变化规律研究. 中草药, 2026 , 57 (2) : 425 -437 . DOI: 10.7501/j.issn.0253-2670.2026.02.005
LAN Tingting, ZHAO Qingrong, YU Daixin, WU Qi'nan, QU Cheng. Dose-effect change rule of characteristic chemical components and in Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos herb pair with different compatibility ratios and antithrombotic activity[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (2) : 425 -437 . DOI: 10.7501/j.issn.0253-2670.2026.02.005

    国家自然科学基金资助项目 (82204597); 南京中医药大学自然科学基金项目 (XPT82204597); 江苏省研究生科研与实践创新计划项目 (KYCX25_2373)

参考文献 引证文献
排序方式:
邓树泳, 李静, 罗来成. 中药药对的现代研究进展[J]. 时珍国医国药, 2012, 23(4):1003-1005.
候宁, 吴东雪, 刘敏, 等. 基于药性组合的丹参和红花的性效关系研究[J]. 中国中药杂志, 2019, 44(2):224-228.
刘玥, 高铸烨, 付长庚, 等. 活血化瘀药物防治冠心病:循证与展望[J]. 中国循证医学杂志, 2018, 18(11):1145-1150.
郝晨伟, 李正翔, 张铭慧, 等. 丹参及其配伍制剂治疗冠心病的研究进展[J]. 中草药, 2021, 52(13):4096-4106.
卜雕雕, 苏卓, 柏希慧, 等. 基于网络药理学的丹参-红花治疗心肌梗死的作用及其机制研究[J]. 中草药, 2020, 51(10):2807-2818.
薛志鹏, 杜少兵, 周慧慧, 等. 基于网络药理学和实验验证的丹参-红花药对治疗心肌缺血的作用机制探讨[J]. 药物评价研究, 2023, 46(4):759-771.
蔡光先. 心宁片治疗冠心病心绞痛临床观察[J]. 世界科学技术-中医药现代化, 2010, 12(4):571-574.
Feng X J, Li Y, Wang Y N, et al. Danhong injection in cardiovascular and cerebrovascular diseases:Pharmacological actions, molecular mechanisms, and therapeutic potential[J]. Pharmacol Res, 2019, 139:62-75.
赖旻. 白癜风胶囊联合芪胶升白胶囊治疗白癜风患者的临床效果研究[J]. 中国实用医药, 2024, 19(9):128-131.
Zhao Q R, Yu D X, Lan T T, et al. Danshen-Honghua herb pair:A review on chemical constituents, pharmacology, clinical application, quality control, and t-copula function analysis[J]. J Ethnopharmacol, 2026, 354:120476.
Lan T T, Yu D X, Zhao Q R, et al. Ethnomedicine, phytochemistry, pharmacology, pharmacokinetics, and clinical application of Salvia miltiorrhiza Bunge (Lamiaceae):A comprehensive review[J]. J Ethnopharmacol, 2025, 350:120032.
Pan J J, Wang J H, Lei Z W, et al. Therapeutic potential of Chinese herbal medicine and underlying mechanism for the treatment of myocardial infarction[J]. Phytother Res, 2025, 39(1):189-232.
邢耀莹, 王姿杨, 王露, 等. 牛蒡子-甘草药对指纹图谱的建立及其抗炎活性谱效关系研究[J]. 中草药, 2024, 55(4):1237-1247.
罗浩睿, 庄雪菲, 李曦东, 等. 黄连-苦参不同配比中特征性成分的量-质变化相关性研究[J]. 中草药, 2024, 55(12):3977-3986.
耿飞飞, 曲彤, 李宁, 等. 青风藤-白芍药对不同配伍比例化学成分与抗炎活性变化规律研究[J]. 中草药, 2025, 56(1):98-107.
李响, 俱蓉, 李硕. 红花化学成分药理作用研究进展及质量标志物预测分析[J]. 中国现代中药, 2021, 23(5):928-939.
Zhang X L, Shen D Y, Feng Y T, et al. Pharmacological actions, molecular mechanisms, pharmacokinetic progressions, and clinical applications of hydroxysafflor yellow A in antidiabetic research[J]. J Immunol Res, 2021, 2021:4560012.
Wang W X, Liu M, Fu X L, et al. Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways[J]. Phytomedicine, 2024, 132:155814.
Feng X T, Du M, Li S J, et al. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE−/− mice[J]. Phytomedicine, 2023, 112:154684.
Hua F, Li J Y, Zhang M, et al. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction[J]. J Food Biochem, 2022, 46(10):e14305.
Xia K R, Zhang X Y, Zhang H Q, et al. Network pharmacology analysis and experimental verification of the antithrombotic active compounds of Trichosanthis Pericarpium (Gualoupi) in treating coronary heart disease[J]. J Ethnopharmacol, 2024, 329:118158.
Oh T W, Do H J, Jeon J H, et al. Quercitrin inhibits platelet activation in arterial thrombosis[J]. Phytomedicine, 2021, 80:153363.
Li H Y, Gao C D, Liu C, et al. A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen[J]. Biomed Pharmacother, 2021, 137:111332.
MEIm X D, Cao Y F, Che Y Y, et al. Danshen:A phytochemical and pharmacological overview[J]. Chin J Nat Med, 2019, 17(1):59-80.
廖江龙, 范子祥, 孟秋月, 等. 丹参活性成分抗肿瘤分子机制研究进展[J]. 中草药, 2024, 55(18):6402-6415.
屈媛, 王婷, 付慧婕, 等. 丹参有效成分及药理作用研究进展[J]. 辽宁中医药大学学报, 2024, 26(9):172-176.
Yang Y F, Feng K, Yuan L Y, et al. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis- induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms[J]. Acta Pharm Sin B, 2023, 13(3):1036-1052.
Li Z M, Xu S W, Liu P Q. Salvia miltiorrhiza Bunge (Danshen):A golden herbal medicine in cardiovascular therapeutics[J]. Acta Pharmacol Sin, 2018, 39(5):802-824.
Xue Y J, Zhang L Y, Zhang L S, et al. Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk[J]. Phytomedicine, 2022, 104:154271.
魏吉昌, 林晓钰, 张景怡, 等. 基于相态变化探讨煎煮方式对黄芩-黄连超分子物质基础及配伍"和合"机制的影响[J]. 中草药, 2024, 55(24):8366-8378.
2026年第57卷第2期
PDF下载
31
10
引用本文
BibTeX
文章信息
doi: 10.7501/j.issn.0253-2670.2026.02.005
  • 接收时间:2025-08-12
  • 首发时间:2026-09-09
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-08-12
基金
作者信息
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.02.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏